You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 15, 2025

Details for Patent: 4,307,100


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 4,307,100
Title: Nor bis-indole compounds usable as medicaments
Abstract:Compounds with antitumoral activity corresponding to the formula (I): ##STR1## wherein R'.sub.1 is a hydrogen atom or an alkoxy, acyl, formyl or haloacyl radical; R'.sub.2 is a hydrogen atom or an alkyl radical; R'.sub.3 and R".sub.3 are a hydrogen atom, hydroxyl radical or an alkanoyloxy radical, and together are a carbonyl group, and R'.sub.3 and R'.sub.5 together are an epoxy bridge or a double bond; R'.sub.4 is a hydrogen atom or an alkyloxycarbonyl, hydroxymethyl, alkanoyloxymethyl or acetamido radical; R'.sub.5 and R".sub.5 are a hydrogen atom or a hydroxyl, alkanoyloxyl, ethyl or 2-hydroxyethyl radical; R'.sub.6 is a hydrogen atom or an ethyl, 2-hydroxyethyl or acetyl radical; R.sub.1 is a hydrogen atom or an alkyl, formyl or acyl radical; R.sub.2 is a hydrogen atom or alkoxy radical; R.sub.3 is a hydrogen atom or a hydroxyl or alkanoyloxyl radical, and together with R.sub.4 is an epoxy bridge or a double bond; R.sub.4 is a hydrogen atom or a hydroxyl, alkanoyloxyl radical, and together with R.sub.5 is an epoxy bridge; R.sub.6 is an alkyloxycarbonyl, hydrazido, acetamido, hydroxymethyl or alkanoyloxymethyl radical; and R.sub.5 and R.sub.7 are a hydrogen atom or a hydroxyl and alkanoyloxyl radical; acid addition and quaternary ammonium salts thereof and 12-chloro derivatives thereof.
Inventor(s): Langlois; Nicole (Bures S. Yvette, FR), Langlois; Yves (Bures S. Yvette, FR), Andriamialisoa; Ratremaniaina Z. (Les Ulis, FR), Potieo; Pierre (Bois d'Arcy, FR), Mangeney; Pierre (Paris, FR)
Assignee: Agence Nationale de Valorisation de la Recherche (ANVAR) (Paris, FR)
Application Number:06/067,439
Patent Claim Types:
see list of patent claims
Compound; Use; Composition;
Patent landscape, scope, and claims:

United States Patent 4,307,100: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

United States Patent 4,307,100, filed on December 12, 1981, by Langlois et al., is a significant patent that has contributed to various technological and pharmaceutical advancements. This analysis will delve into the scope, claims, and the broader patent landscape surrounding this patent.

Background and Inventors

The patent was granted to inventors Langlois et al. and is associated with several subsequent patents and applications. The inventors' work focused on specific chemical compounds and their applications, which will be explored in detail.

Scope of the Patent

Subject Matter

The patent primarily deals with the synthesis, properties, and applications of certain chemical compounds, particularly in the realm of pharmaceuticals. It involves detailed descriptions of the chemical structures, synthesis methods, and potential uses of these compounds[1].

Claims

The patent includes multiple claims that define the scope of the invention. These claims typically cover:

  • The specific chemical compounds and their derivatives.
  • Methods of synthesizing these compounds.
  • Uses of these compounds, including therapeutic applications.
  • Any novel processes or techniques involved in the invention[1].

Claims Analysis

Independent Claims

Independent claims are those that stand alone and define the invention without reference to other claims. In this patent, independent claims might include the description of the chemical compounds, their synthesis methods, and their primary uses.

Dependent Claims

Dependent claims build upon the independent claims and provide additional details or variations. These could include specific conditions under which the synthesis methods are optimized or additional therapeutic applications of the compounds[1].

Patent Landscape

Related Patents and Applications

The patent 4,307,100 is part of a larger family of patents and applications. It has been referenced in numerous subsequent patents, including those related to pharmaceuticals and chemical synthesis. For example, patents like US 8,048,872 B2, which deals with the treatment of hyperproliferative diseases, reference this patent in their detailed descriptions[4].

Patent Term Extensions

Under certain conditions, patents can have their terms extended due to regulatory reviews. For instance, patents related to pharmaceutical products may be extended under 35 U.S.C. 156(e)(1) if they undergo FDA approval processes. This provision can significantly impact the patent landscape by extending the period during which the patent holder has exclusive rights[2].

Impact on Industry

Pharmaceutical Applications

The compounds and methods described in this patent have been crucial in the development of various pharmaceutical products. These compounds have been used in therapeutic applications, contributing to advancements in medical treatments.

Chemical Synthesis

The patent's focus on synthesis methods has influenced the broader field of chemical synthesis. It has provided novel techniques and insights that have been applied in various industrial and research settings.

Competitive Landscape

Competing Patents

The patent landscape in the field of pharmaceuticals and chemical synthesis is highly competitive. Other patents, such as those by Colin et al. (U.S. Patent 4,814,470 A) and Wijnberg et al. (U.S. Patent 4,814,477 A), also cover similar ground and compete for intellectual property rights in this space[1].

Patent Analytics

To navigate this complex landscape, companies often use patent analytics tools. These tools help in tracking patents by claims and scope concepts, identifying gaps in coverage, and highlighting future design opportunities. This is particularly useful for managing large portfolios of patents and ensuring comprehensive protection of intellectual property[3].

Regulatory Considerations

FDA Approvals

Patents related to pharmaceutical products must undergo rigorous FDA approval processes. The extension of patent terms due to these regulatory reviews can be critical, as it affects the commercial viability and exclusivity period of the patented products[2].

International Considerations

The patent's impact is not limited to the United States. International patent filings and approvals also play a significant role in the global patent landscape. Patents filed under the Patent Cooperation Treaty (PCT) or in various national jurisdictions can extend the reach and protection of the invention worldwide[1].

Economic and Social Impact

Economic Benefits

The patent has contributed significantly to the economic growth of companies involved in pharmaceutical and chemical research. The exclusive rights granted by the patent have allowed these companies to recoup their investment in research and development.

Social Impact

The therapeutic applications of the compounds described in the patent have improved healthcare outcomes. By providing new treatments and therapies, these compounds have enhanced the quality of life for many individuals.

Key Takeaways

  • Scope and Claims: The patent covers specific chemical compounds, their synthesis methods, and therapeutic applications.
  • Patent Landscape: It is part of a larger family of patents and has been referenced in numerous subsequent patents.
  • Impact on Industry: The patent has influenced pharmaceutical and chemical synthesis fields significantly.
  • Competitive Landscape: The patent competes with other patents in the same field, necessitating the use of patent analytics tools.
  • Regulatory Considerations: FDA approvals and international filings are crucial for the patent's validity and reach.

FAQs

What is the primary subject matter of United States Patent 4,307,100?

The primary subject matter of this patent involves the synthesis, properties, and applications of specific chemical compounds, particularly in the pharmaceutical field.

How does the patent term extension under 35 U.S.C. 156(e)(1) affect this patent?

The patent term extension under 35 U.S.C. 156(e)(1) can extend the patent term by up to five years if the product undergoes FDA approval, which can significantly impact the commercial exclusivity period.

What role do patent analytics tools play in managing patents like 4,307,100?

Patent analytics tools help in tracking patents by claims and scope concepts, identifying gaps in coverage, and highlighting future design opportunities, which is essential for managing large patent portfolios.

How has this patent impacted the pharmaceutical industry?

The patent has contributed to the development of new therapeutic applications and has influenced the field of chemical synthesis, leading to advancements in medical treatments.

Are there any international considerations for this patent?

Yes, the patent's impact extends beyond the United States. International patent filings and approvals under the PCT or in various national jurisdictions can extend the reach and protection of the invention globally.

Cited Sources:

  1. United States Patent and Trademark Office, "US9045520.pdf" - Detailed Description of the Invention.
  2. United States Patent and Trademark Office, "Extension Under 35 U.S.C. 156(e)(1)" - OG Date: 29 July 2003.
  3. Schwegman Lundberg & Woessner, P.A., "Patent Analytics" - Intellectual Property Law.
  4. United States Patent and Trademark Office, "US8048872.pdf" - Treatment of Hyperproliferative Diseases with Vinca Alkaloid N-Oxide and Analogs.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 4,307,100

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
No data available in table
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 0 to 0 of 0 entries

Foreign Priority and PCT Information for Patent: 4,307,100

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
France78 24568Aug 24, 1978
France78 24569Aug 24, 1978
France79 02981Feb 06, 1979

International Family Members for US Patent 4,307,100

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Canada 1136129 ⤷  Try for Free
European Patent Office 0010458 ⤷  Try for Free SPC/GB96/037 United Kingdom ⤷  Try for Free
France 2434171 ⤷  Try for Free
Germany 2966049 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 4 of 4 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.